Testing Strategies in Precision Oncology
This channel delivers news and educational resources on the latest advances in diagnostic testing for precision oncology. Topics include comprehensive genomic profiling for solid tumors and hematologic malignancies, immune profiling, liquid biopsy, PD-L1 testing, and companion diagnostics — empowering healthcare professionals to stay informed on innovations shaping personalized cancer care.
At the AACR annual meeting, investigators presented promising data across genomic and protein-based technologies, highlighting synergies that could improve performance.
Promega Microsatellite Instability Detection Kit Garners China NMPA Approval
The ProDx MSI Detection Kit is now available for clinical testing in China to screen for colorectal cancer patients who may benefit from additional Lynch syndrome testing.
Investigators reported on the firm's ctDNA residual disease assay to detect disease in colorectal patients during the ideal window for guiding therapy.
When patients with solid tumors had the same findings using liquid- and tissue-based tests from Foundation Medicine, patients had better outcomes on molecular tumor board-guided therapy.
EntroGen Colorectal Cancer RAS Mutation Detection Test Nabs CMS Coverage
The real-time PCR-based companion diagnostic test identifies patients eligible for treatment with Amgen's Vectibix (panitumumab).
